AI assistant
Cartesian Therapeutics, Inc. — Director's Dealing 2023
Nov 15, 2023
33483_dirs_2023-11-15_eab56add-d8d5-4ebe-ac78-f22c08f54429.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cartesian Therapeutics, Inc. (RNAC)
CIK: 0001453687
Period of Report: 2023-11-13
Reporting Person: BARABE TIMOTHY C (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-11-13 | Stock Option (Right to Buy) | $11 | D | 10328 | Disposed | 2026-07-28 | Common Stock (10328) | Direct |
| 2023-11-13 | Stock Option (Right to Buy) | $17.47 | D | 6410 | Disposed | 2027-06-15 | Common Stock (6410) | Direct |
| 2023-11-13 | Stock Option (Right to Buy) | $12.75 | D | 10000 | Disposed | 2028-06-14 | Common Stock (10000) | Direct |
| 2023-11-13 | Stock Option (Right to Buy) | $3 | D | 20000 | Disposed | 2030-06-18 | Common Stock (20000) | Direct |
| 2023-11-13 | Stock Option (Right to Buy) | $4.01 | D | 40000 | Disposed | 2031-03-29 | Common Stock (40000) | Direct |
| 2023-11-13 | Stock Option (Right to Buy) | $3.31 | D | 40000 | Disposed | 2032-01-02 | Common Stock (40000) | Direct |
| 2023-11-13 | Stock Option (Right to Buy) | $1.13 | D | 87500 | Disposed | 2033-01-01 | Common Stock (87500) | Direct |
Footnotes
F1: This option, which provided for vesting in thirty-six (36) substantially equal monthly installments over three years following the date of grant on July 29, 2016, was canceled in the merger (the "Merger") between Selecta Biosciences, Inc. and Cartesian Therapeutics, Inc.
F2: This option, which provided for vesting in full on June 14, 2018, was canceled in the Merger.
F3: This option, which provided for vesting in full on June 13, 2019, was canceled in the Merger.
F4: This option, which provided for vesting in full on June 17, 2021, was canceled in the Merger.
F5: This option, which provided for vesting in full on March 30, 2022, was canceled in the Merger.
F6: This option, which provided for vesting in full on January 3, 2023, was canceled in the Merger.
F7: This option, which provided for vesting in full on January 2, 2024, was canceled in the Merger in exchange for a cash payment of $81,375, representing the difference between the exercise price of the option and $2.06, the Cash-out Amount as applied in the Merger.